Regeneron(REGN) - 2023 Q1 - Earnings Call Transcript

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Ryan Crowe - Investor Relations Leonard Schleifer - Chief Executive Officer George Yancopoulos - Co-Founder, President and Chief Scientific Officer Marion McCourt - Executive Vice President and Head of Commercial Bob Landry - Chief Financial Officer Conference Call Participants Mohit Bansal - Wells Fargo Robyn Karnauskas - Truist Tyler Van Buren - Cowen Terence Flynn - Morgan Stanley Chri ...